UBS Group’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
Other funds holding GH
UBS Group's GH Position: Q3 2026 in Review
UBS Group increased its Guardant Health (GH) stake by 33% in Q3 2026, buying an estimated $46.3M and bringing the position to 1,149,570 shares worth $205M. The position accounts for 0.03% of the portfolio, ranked #642.
UBS Group first reported a position in GH in Q4 2018 and has held it in 32 quarters since. 676 funds tracked by Wall St. Rank hold GH as of Q3 2026.
- UBS Group held 1,149,570 shares of Guardant Health worth $205M as of Q3 2026.
- UBS Group bought 283,524 Guardant Health shares in Q3 2026, an estimated $46.3M.
- Guardant Health made up 0.03% of UBS Group's portfolio in Q3 2026, its #642 holding.
- UBS Group first reported a position in Guardant Health in Q4 2018 and has held it in 32 quarters since.
- 676 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.